Login Register Cart 0

Articles by Disease (Islet Cell Cancer)

Can We Use mTOR Inhibitors for COVID-19 Therapy?

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 25
Page: 1805-1808
Author(s): Ina Y. Aneva *, Solomon Habtemariam, Maciej Banach, Parames C. Sil , Kasturi Sarkar, Adeleh Sahebnasagh , Mohammad Amjad Kamal, Maryam Khayatkashani and Hamid Reza Khayat Kashani*

The Putative Adverse Effects of Bisphenol A on Autoimmune Diseases

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22
Page: 665-676
Author(s): Kassem Sharif, Adam Kurnick, Louis Coplan, Matthew Alexander, Abdulla Watad, Howard Amital and Yehuda Shoenfeld*

MicroRNA-7 Regulates Insulin Signaling Pathway by Targeting IRS1, IRS2, and RAF1 Genes in Gestational Diabetes Mellitus

Journal: MicroRNA
Volume: 11
Page: 57-72
Author(s): Ravi Bhushan, Anjali Rani, Deepali Gupta, Akhtar Ali and Pawan K. Dubey*

A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer

Journal: Current Drug Targets
Volume: 23
Page: 836-853
Author(s): Rudra Chakravarti, Swadhin Kumar Lenka, Anupam Gautam, Rajveer Singh, Velayutham Ravichandiran, Syamal Roy and Dipanjan Ghosh*

Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular Mechanisms

Journal: Current Molecular Pharmacology
Volume: 15
Page: 846-861
Author(s): Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou and Yunxia Li*

H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications

Journal: Current Pharmaceutical Design
Volume: 28
Page: 1011-1018
Author(s): Leiqi Zhu, Yuanyang Li, Fangqi Xia, Mengzhen Xue, Yaqi Wang, Dengke Jia, Yan Gao, Luoying Li, Yue Shi, Silong Chen, Guangfu Xu and Chengfu Yuan*

Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention

Journal: Current Drug Targets
Volume: 23
Page: 761-767
Author(s): Rajesh Basnet*, Til Bahadur Basnet, Buddha Bahadur Basnet and Sandhya Khadka

Eugenol Elicits Prolongevity by Increasing Resistance to Oxidative Stress in C. elegans

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21
Page: 841-853
Author(s): Nikhat Parween, Amber Jabeen and Birendra Prasad*

Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications

Journal: Current Drug Targets
Volume: 23
Page: 692-710
Author(s): Lin Yang, Zhixin Zhang, Doudou Wang, Yu Jiang* and Ying Liu*

Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions

Journal: Current Topics in Medicinal Chemistry
Volume: 22
Page: 891-920
Author(s): Mohammad Malekan and Mohammad Ali Ebrahimzadeh*


© 2024 Bentham Science Publishers | Privacy Policy